-
-
在线客服
-
-
-
-
我的收藏
-
我的订单
-
快速订购
-
-
-
| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| A998903 | Anti-Integrin a4b7 (ITGA4 & ITGB7) Reference Antibody (vedolizumab), Anti-Integrin a4b7 (ITGA4 & ITGB7) Reference Antibody (vedolizumab), |
|||
| A998904 | Anti-Integrin a5b1 (ITGA5 & ITGB1) Reference Antibody (BMS patent anti-Integrin α5β1), Anti-Integrin a5b1 (ITGA5 & ITGB1) Reference Antibody (BMS patent anti-Integrin α5β1), |
|||
| A998905 | Anti-Integrin a5b1 (ITGA5 & ITGB1) Reference Antibody (volociximab), Anti-Integrin a5b1 (ITGA5 & ITGB1) Reference Antibody (volociximab), |
|||
| A998906 | Anti-Integrin aL / ITGAL / CD11a Reference Antibody (efalizumab), Anti-Integrin aL / ITGAL / CD11a Reference Antibody (efalizumab), |
|||
| A998907 | Anti-Integrin aV / ITGAV / CD51 Reference Antibody (abituzumab), Anti-Integrin aV / ITGAV / CD51 Reference Antibody (abituzumab), |
|||
| A998908 | Anti-Integrin aV / ITGAV / CD51 Reference Antibody (intetumumab), Anti-Integrin aV / ITGAV / CD51 Reference Antibody (intetumumab), |
|||
| A998909 | Anti-Integrin aVb3 (ITGAV & ITGB3) Reference Antibody (etaracizumab), Anti-Integrin aVb3 (ITGAV & ITGB3) Reference Antibody (etaracizumab), |
|||
| A998910 | Anti-Integrin aVb6 (ITGAV & ITGB6) Reference Antibody (STX-100), Anti-Integrin aVb6 (ITGAV & ITGB6) Reference Antibody (STX-100), |
|||
| A998911 | Anti-Integrin b1 / ITGB1 / CD29 Reference Antibody (OS2966), Anti-Integrin b1 / ITGB1 / CD29 Reference Antibody (OS2966), |
|||
| A998912 | Anti-Integrin b2 / ITGB2 / CD18 Reference Antibody (erlizumab), Anti-Integrin b2 / ITGB2 / CD18 Reference Antibody (erlizumab), |
|||
| A998913 | Anti-Integrin b7 / ITGB7 Reference Antibody (Genentech patent anti-Integrin β7), Anti-Integrin b7 / ITGB7 Reference Antibody (Genentech patent anti-Integrin β7), |
|||
| A998914 | Anti-KAAG1 Reference Antibody (ADCT-901), Anti-KAAG1 Reference Antibody (ADCT-901), |
|||
| A998915 | Anti-KID3 Reference Antibody (Macrogenics patent anti-KID3), Anti-KID3 Reference Antibody (Macrogenics patent anti-KID3), |
|||
| A998916 | Anti-KIR Reference Antibody (lirilumab), Anti-KIR Reference Antibody (lirilumab), |
|||
| A998917 | Anti-KIR2DL1 / CD158a Reference Antibody (Innate patent anti-KIR2DL), Anti-KIR2DL1 / CD158a Reference Antibody (Innate patent anti-KIR2DL), |
|||
| A998918 | Anti-KIR3DL2 / CD158k Reference Antibody (lacutamab), Anti-KIR3DL2 / CD158k Reference Antibody (lacutamab), |
|||
| A998919 | Anti-KLK2 / Kallikrein 2 Reference Antibody (JNJ-69086420), Anti-KLK2 / Kallikrein 2 Reference Antibody (JNJ-69086420), |
|||
| A998920 | Anti-KLK5 / Kallikrein 5 Reference Antibody (Genentech patent anti-KLK5), Anti-KLK5 / Kallikrein 5 Reference Antibody (Genentech patent anti-KLK5), |
|||
| A998921 | Anti-Klotho Beta Reference Antibody (NGM313), Anti-Klotho Beta Reference Antibody (NGM313), |
|||
| A998922 | Anti-Klotho Beta Reference Antibody (RG7992), Anti-Klotho Beta Reference Antibody (RG7992), |
